Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-06

Clinical Trial Update: Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MyStar DoseCoach-guided dose titration to routine titration in adults with Type 2 Diabetes Mellitus treated with Toujeo (insulin glargin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TOUJEO (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED